|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/24 | (2006.01) |
| A61K 31/192 | (2006.01) |
| (11) | Number of the document | 3359139 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15791391.4 |
| Date of filing the European patent application | 2015-10-09 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/054873 |
| Date | 2015-10-09 |
| (87) | Number | WO 2017/062027 |
| Date | 2017-04-13 |
| (72) |
SIRIHORACHAI, Rachan , US
ROSAR, Paul , US
|
| (73) |
Bayer HealthCare LLC ,
100 Bayer Boulevard
PO Box 915, Whippany, NJ 07981,
US
|
| (54) | MODIFIED RELEASE FORMULATION OF NAPROXEN SODIUM |
| MODIFIED RELEASE FORMULATION OF NAPROXEN SODIUM |